TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

ILLUMINA

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

ILLUMINA

ST13

US500000087750316

Classe

35, 36, 41, 42, 44, 45

Pedido

87750316

Registro

6511719

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

51

Atualização mais recente

05/11/2025

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

35, 36, 41, 42, 44, 45

Data de depósito

10/01/2018

Data de registro

05/10/2021

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

05/10/2021

Última transação

05/11/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Fundamento do pedido

Intent to use

Primeiro uso

26/01/2001

Primeiro uso no comércio

26/01/2001

Código do desenho

4

Tipo de titular

03

Localização do titular

San Diego, CA

Examinador

HARMON,RAYMOND E

Unidade examinadora

L30

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

Illumina, Inc.
Illumina Inc.

Representantes

Susan M. Natland Baker & Hostetler LLP

Classificação técnica

Classes Nice

Classe 35Classe 36Classe 41Classe 42Classe 44Classe 45

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 35

Promoting collaboration and the exchange of information and resources within the cooperative scientific, research, medical, and provider community to achieve advances in the fields of nucleic acid sequencing and genotyping, medical diagnostics, clinical diagnostics, medical research, clinical research, life sciences, biology, molecular pathology, molecular diagnostics, laboratory medicine, biotechnology, agriculture, forensics, and genetics

Classe 36

Financing services; Warranty services, namely, providing extended warranties on laboratory equipment, namely, genomic sequencers and molecular diagnostics, scientific apparatus and instruments, namely, genomic sequencers and molecular diagnostics

Classe 41

Educational services, namely, providing seminars, workshops, customer trainings and tutorials in the fields of and for use in the fields of nucleic acid sequencing, genotyping, medical diagnostics, veterinary diagnostics, clinical diagnostics, medical research, veterinary research, diagnostics, clinical research, drug development, drug development research, medical laboratory research, veterinary science and research, life sciences, biology, microbiology, metagenomics, biotechnology, agriculture, forensics, food safety, and genetics; Providing non-downloadable electronic newsletters and online electronic newsletters delivered via email for use in the fields of nucleic acid sequencing, genotyping, medical diagnostics, veterinary diagnostics, clinical diagnostics, medical research, veterinary research, diagnostics, clinical research, drug development, drug development research, medical laboratory research, veterinary science and research, life sciences, biology, microbiology, biotechnology, agriculture, forensics, food safety, metagenomics, and genetics; Educational services, namely, providing training of clinicians, scientists, researchers and medical professionals for certification in the use of scientific equipment and instruments, namely, genomic sequencers and molecular diagnostics automated laboratory apparatus, namely, genomic sequencers and molecular diagnostics, and laboratory equipment, namely, genomic sequencers and molecular diagnostics; Providing facilities for training in operation and use of scientific equipment and instruments, namely, genomic sequencers and molecular diagnostics, automated laboratory apparatus, namely, genomic sequencers and molecular diagnostics, and laboratory equipment, namely, genomic sequencers and molecular diagnostics

Classe 42

Computer services, namely, providing an online community for subscribers to participate by sharing and posting articles, videos, and other content, namely, findings in the fields of nucleic acid sequencing and genotyping, medical diagnostics, clinical diagnostics, medical research, clinical research, life sciences, biology, molecular diagnostics, laboratory medicine, biotechnology, agriculture, forensics, and genetics; Research services, namely, case studies in the fields of and for use in the fields of nucleic acid sequencing, genotyping, medical diagnostics, veterinary diagnostics, clinical diagnostics, medical research, veterinary research, diagnostics, clinical research, drug development, drug development research, medical laboratory research, veterinary science and research, life sciences, biology, microbiology, metagenomics, biotechnology, agriculture, forensics, food safety, and genetics; Leasing of laboratory equipment, namely, genomic sequencers and molecular diagnostics, scientific apparatus and instruments, namely, genomic sequencers and molecular diagnostics; Medical research services in the field of genotyping, diagnostics, molecular pathology, molecular diagnostics, laboratory medicine, and oncology; DNA sequencing, screening, and analysis services for medical research purposes; Nucleic acid sequencing, screening, and analysis services for medical research purposes; Genomic sequencing, screening, and analysis services for medical research purposes; genetic analysis and reporting services for medical research purposes

Classe 44

Medical testing for diagnostic or treatment purposes; DNA sequencing, screening, and analysis services for medical diagnostic purposes; Nucleic acid sequencing, screening, and analysis services for medical diagnostic purposes; Genomic sequencing, screening, and analysis services for medical diagnostic purposes; genetic analysis and reporting services for medical diagnostic purposes; Medical diagnostic testing, monitoring and reporting services in the field of infectious disease identification and surveillance

Classe 45

Online social networking services

Publicações

Histórico de despachos e eventos da marca no USPTO.

51 publicações encontradas

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

29/10/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

29/10/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

29/10/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

29/10/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

29/10/2025

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

29/10/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

05/10/2021

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

03/09/2021

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

02/09/2021

SUPC

STATEMENT OF USE PROCESSING COMPLETE

02/09/2021

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

01/09/2021

IUAF

USE AMENDMENT FILED

30/08/2021

EISU

TEAS STATEMENT OF USE RECEIVED

30/08/2021

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

03/03/2021

EX4G

SOU EXTENSION 4 GRANTED

01/03/2021

EXT4

SOU EXTENSION 4 FILED

01/03/2021

EEXT

SOU TEAS EXTENSION RECEIVED

01/03/2021

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

01/09/2020

EX3G

SOU EXTENSION 3 GRANTED

28/08/2020

EXT3

SOU EXTENSION 3 FILED

28/08/2020

EEXT

SOU TEAS EXTENSION RECEIVED

28/08/2020

EPPA

TEAS POST PUBLICATION AMENDMENT RECEIVED

25/06/2020

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

27/02/2020

EX2G

SOU EXTENSION 2 GRANTED

25/02/2020

EXT2

SOU EXTENSION 2 FILED

25/02/2020

EEXT

SOU TEAS EXTENSION RECEIVED

25/02/2020

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

05/09/2019

EX1G

SOU EXTENSION 1 GRANTED

03/09/2019

EXT1

SOU EXTENSION 1 FILED

03/09/2019

EEXT

SOU TEAS EXTENSION RECEIVED

03/09/2019

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

21/08/2019

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

21/08/2019

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

05/03/2019

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/01/2019

PUBO

PUBLISHED FOR OPPOSITION

08/01/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

19/12/2018

ALIE

ASSIGNED TO LIE

29/11/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/11/2018

XAEC

EXAMINER'S AMENDMENT ENTERED

08/11/2018

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

08/11/2018

GNEA

EXAMINERS AMENDMENT E-MAILED

08/11/2018

CNEA

EXAMINERS AMENDMENT -WRITTEN

08/11/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

25/10/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

25/10/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

25/10/2018

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

25/04/2018

GNRT

NON-FINAL ACTION E-MAILED

25/04/2018

CNRT

NON-FINAL ACTION WRITTEN

25/04/2018

DOCK

ASSIGNED TO EXAMINER

19/04/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

24/01/2018

NWAP

NEW APPLICATION ENTERED

13/01/2018

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace ILLUMINA ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.